Original article
Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients
Estrategias de anticoagulación y riesgo de sangrado en pacientes ingresados en una Unidad de Cuidados Intensivos por COVID-19
C. Gabaraa, B. Solaratb, P. Castroa,c, S. Fernándeza,c, J.R. Badiab, D. Toapantad, S. Schulmane,f, J.C. Reverterg, A. Sorianoh, J. Moisésb,1,
, J. Aibara,1,2
Corresponding author
a Internal Medicine Department, Hospital Clínic, IDIBAPS – University of Barcelona, Spain
b Pneumology Department, Hospital Clínic, IDIBAPS – University of Barcelona, Spain
c Medical Intensive Care Unit, Hospital Clínic, IDIBAPS – University of Barcelona, Spain
d Liver ICU, Hospital Clínic, IDIBAPS – University of Barcelona, Spain
e Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada
f Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
g Hematology Department, Hospital Clínic, IDIBAPS – University of Barcelona, Spain
h Infectious Disease Department, Hospital Clínic, IDIBAPS – University of Barcelona, Spain
Read
2520
Timeswas read the article
886
Total PDF
1634
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 4 | 10 | 14 |
| 2025 5 | 113 | 43 | 156 |
| 2025 4 | 73 | 34 | 107 |
| 2025 3 | 75 | 30 | 105 |
| 2025 2 | 149 | 31 | 180 |
| 2025 1 | 86 | 53 | 139 |
| 2024 12 | 69 | 51 | 120 |
| 2024 11 | 63 | 48 | 111 |
| 2024 10 | 60 | 51 | 111 |
| 2024 9 | 54 | 32 | 86 |
| 2024 8 | 62 | 37 | 99 |
| 2024 7 | 42 | 22 | 64 |
| 2024 6 | 47 | 31 | 78 |
| 2024 5 | 43 | 32 | 75 |
| 2024 4 | 63 | 33 | 96 |
| 2024 3 | 55 | 21 | 76 |
| 2024 2 | 76 | 30 | 106 |
| 2024 1 | 55 | 30 | 85 |
| 2023 12 | 87 | 44 | 131 |
| 2023 11 | 50 | 39 | 89 |
| 2023 10 | 72 | 32 | 104 |
| 2023 9 | 50 | 40 | 90 |
| 2023 8 | 27 | 21 | 48 |
| 2023 7 | 45 | 24 | 69 |
| 2023 6 | 32 | 19 | 51 |
| 2023 5 | 40 | 25 | 65 |
| 2023 4 | 36 | 20 | 56 |
| 2023 3 | 5 | 3 | 8 |
| 2023 1 | 1 | 0 | 1 |
Show all
